Table 1.

Demonstration of reproducible results

Published Results
Overall survival	Events/Evaluable	Hazard Ratio (95% confidence interval)	p-value
Age
≤12 years	22/491	1.00
13 – 49 years	54/419	3.15 (1.86 – 5.34)	<0.0001
Regimen intensity
Non-myeloablative	7/181	1.00
Myeloablative	41/478	4.62 (1.87 – 11.44)	0.0009
Reduced intensity	28/251	3.79 (1.46 – 9.84)	0.006
Donor type
HLA-matched sibling	21/558	1.00
Haploidentical relative	13/137	2.94 (1.26 – 6.87)	0.013
HLA-matched unrelated	26/111	5.12 (2.79 – 9.40)	<0.0001
HLA-mismatched unrelated	16/104	4.88 (2.22 – 10.75)	<0.0001
Results from Public Database with Additional Follow up for Published Cohort
Overall survival	Events/Evaluable	Hazard Ratio (95% confidence interval)	p-value
Age
≤12 years	23/491	1.00
13 – 49 years	59/419	3.50 (2.16 – 5.79)	<0.0001
Regimen intensity
Non-myeloablative	9/181	1.00
Myeloablative	44/478	3.59 (1.57 – 8.21)	0.002
Reduced intensity	29/251	3.08 (1.29 – 7.39)	0.012
Donor type
HLA-matched sibling	25/558	1.00
Haploidentical relative	13/137	2.70 (1.29 – 5.67)	0.009
HLA-matched unrelated	27/111	4.36 (2.47 – 7.70)	<0.0001
HLA-mismatched unrelated	17/104	3.55 (1.90 – 6.65)	<0.0001